Dr Dale Bredesen sits down with Dr Daniel and Tana Amen to discuss the serious threat Alzheimer's disease still represents to the world’s population. Bredesen shares how difficult getting a simple trial approved by the Institutional Review Board can be and how some groundbreaking work is being overshadowed, thanks to corporate interest.